Amrize Ltd
NYSE:AMRZConstruction Materials
+$1.05 today
- Market cap
- $22.10B
- Beta
- -0.09
Volume 3.68M
Average 3.11M
AMRZ EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
Amrize LtdNYSE: AMRZ
EPS (Diluted) · Q2 FY2026 · quarter ended Jun 2026
EPS (Diluted) growth accelerates
Q2 FY2026 EPS (Diluted) of $0.86 rose 10.3% year over year, ahead of the -11.8% change in trailing-twelve-month EPS (Diluted). Over 3 fiscal years it compounded at +2.3% a year.
Context
- EPS (Diluted) increased in 1 of the last 3 fiscal years.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 8 analysts of $2.35 (+9.7%) for the fiscal year ending Dec 2026, a step up from the -7.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $0.86+509.5% QoQ
- Last fiscal yearDec 2025
- $2.14-7.0% YoY
- LTMJun 2026
- $2.18-11.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +10.3% | +4.1% | -6.2 pp |
| 1 year | -7.0% | +9.7% | +16.6 pp |
| 3-year CAGR | +2.3% | +11.6% | +9.3 pp |
| 5-year CAGR | +11.3% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 2.14 USD
- Year-over-year change
- -7.0%
- 4-year CAGR
- +8.9%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.14 | -7.0% |
| FY2024 | 2024-12-31 | 2.30 | +32.9% |
| FY2023 | 2023-12-31 | 1.73 | -13.5% |
| FY2022 | 2022-12-31 | 2.00 | +31.6% |
| FY2021 | 2021-12-31 | 1.52 | — |
EPS (Diluted) vs competitors
How AMRZ compares with its peers on the latest reported figures
- AMRZ's LTM Jun 2026 EPS (Diluted) of $2.18 is the 6th highest of the 7 companies compared; the peer median is $10.57.
- Its year-over-year change of -11.8% is the 6th highest of 7, against a peer median of +7.8%.
- Over three fiscal years its annual growth of +2.3% compares with a peer median of +3.1%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $40.7 | +125.7% | +10.7% | |
| LTM Jun 2026 | $17.4 | -3.1% | -0.8% | |
| LTM Jun 2026 | $12.65 | -6.8% | +1.7% | |
| LTM Jun 2026 | $8.48 | +18.6% | +23.5% | |
| LTM Jun 2026 | $5.67 | +18.6% | +3.1% | |
AMRZAmrize Ltd | LTM Jun 2026 | $2.18 | -11.8% | +2.3% |
| LTM Jun 2026 | -$8.15 | -310.1% | — | |
| Peer median (excluding AMRZ) | $10.57 | +7.8% | +3.1% | |
Competitors are the stored peer set for AMRZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 8.13B | 10.73B | 11.68B | 11.7B | 11.82B |
| Cost of Revenue | 6.31B | 8.25B | 8.91B | 8.63B | 8.78B |
| Gross Profit | 1.82B | 2.47B | 2.77B | 3.07B | 3.03B |
| Gross Margin | 22.4% | 23.0% | 23.7% | 26.2% | 25.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 552M | 752M | 898M | 944M | 1.13B |
| Operating Expenses | 530M | 773M | 881M | 944M | 1.13B |
| Depreciation & Amortization | 712M | 788M | 851M | 875M | 914M |
| EBITDA | 2.01B | 2.5B | 2.7B | 3.02B | 2.82B |
| EBITDA Margin | 24.7% | 23.3% | 23.1% | 25.8% | 23.9% |
| Operating Income | 1.29B | 1.7B | 1.89B | 2.13B | 1.91B |
| Operating Margin | 15.8% | 15.8% | 16.2% | 18.2% | 16.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 178M | 248M | 549M | 302M | 413M |
| Other Income / Expenses | (161M) | (226M) | (572M) | (485M) | (398M) |
| Income Before Tax | 1.13B | 1.47B | 1.32B | 1.64B | 1.51B |
| Pre-Tax Margin | 13.9% | 13.7% | 11.3% | 14.0% | 12.8% |
| Income Tax Expense | 284M | 366M | 361M | 368M | 326M |
| Net Income | 841M | 1.11B | 956M | 1.27B | 1.19B |
| Net Margin | 10.3% | 10.3% | 8.2% | 10.9% | 10.0% |
| EPS (Basic) | 1.52 | 2.00 | 1.73 | 2.30 | 2.14 |
| EPS (Diluted) | 1.52 | 2.00 | 1.73 | 2.30 | 2.14 |
| Weighted Avg Shares | 552.7M | 552.7M | 552.7M | 553.3M | 553.6M |
| Weighted Avg Shares (Diluted) | 552.7M | 552.7M | 552.7M | 553.3M | 553.6M |
Amrize Ltd
NYSE:AMRZ
Intrinsic Alpha fair value
Locked
Current Price
$40.41
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.